Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.6 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |